ÌÒ»¨ÉçÇøÊÓƵ

Working with Industry Partners

The Center for Bioelectrics' primary mission is to carry out scientific research that increases our understanding of the interaction of electromagnetic fields and ionized gases with biological systems, and to use this knowledge to optimize and develop applications in biotechnology, medical diagnostics and therapeutics. From time to time, research interests of Center faculty converge with an industrial entity seeking answers to similar scientific questions, and the opportunity for industry to sponsor research at the Center arises. The Center supports and welcomes industry-sponsored projects that promote scientific advancements and stimulate the effective use of new knowledge.

Pulse Biosciences

is a bioelectric medicine company focused on technology and products utilizing nanosecond electric pulses to treat a range of dermatologic conditions and tumors. The technology originated at the Frank Reidy Research Center for Bioelectrics at ÌÒ»¨ÉçÇøÊÓƵ Dominion University and in the labs of Professor Martin Gundersen in the Department of Electrical Engineering at the University of Southern California. The spinout of this bioelectrics technology to Pulse Biosciences was a first for ÌÒ»¨ÉçÇøÊÓƵ Dominion University and an example of a university-developed technology reaching the marketplace. Bioelectrics' pathbreaking work has been recognized as the most successful university-based initial public offering (IPO) in the stock market-ever and the largest single commercialization effort achieved at ÌÒ»¨ÉçÇøÊÓƵ Dominion University. The Pulse Bioesciences' IPO resulted in a revenue of approximately $41 million to ÌÒ»¨ÉçÇøÊÓƵ Dominion University and its inventors.

The CellFX® System is the first commercially available product to harness the distinctive advantages of Nano-Pulse Stimulation (NPS™) technology. Initial target applications are a range of dermatologic conditions that share high demand among patients and practitioners for improved outcomes. The CellFX® System has received FDA, CE mark and Health Canada approvals.

Ìý

From left to right: Engineering prototype developed at the Center, two models developed in the Pulse Biosciences' engineering lab and the final commercial CellFX® system